Zobrazeno 1 - 10
of 726
pro vyhledávání: '"Henry, Walter A."'
Autor:
Zielske, Hubert A.1,2, Henry, Walter A.3
Publikováno v:
Journal of Advertising Research. Apr80, Vol. 20 Issue 2, p7. 7p.
Autor:
Henry, Walter A.1
Publikováno v:
Journal of Consumer Research. Jun80, Vol. 7 Issue 1, p42-48. 7p.
Autor:
Henry, Walter A.1
Publikováno v:
Journal of Marketing Research (JMR). May76, Vol. 13 Issue 2, p121-127. 7p. 9 Charts.
Autor:
Henry, Walter A.1, Stumpf, Robert V.2
Publikováno v:
Journal of Marketing Research (JMR). May75, Vol. 12 Issue 2, p165-170. 6p. 1 Diagram, 3 Charts, 1 Graph.
Autor:
Parsons, Leonard J.1, Henry, Walter A.2
Publikováno v:
Journal of Marketing Research (JMR). Nov72, Vol. 9 Issue 4, p391-395. 5p. 4 Graphs.
Autor:
Robert Fred Henry Walter, Robert Werner, Claudia Vollbrecht, Thomas Hager, Elena Flom, Daniel Christian Christoph, Jan Schmeller, Kurt Werner Schmid, Jeremias Wohlschlaeger, Fabian Dominik Mairinger
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165181 (2016)
Neuroendocrine lung cancer (NELC) represents 25% of all lung cancer cases and large patient collectives exist as formalin-fixed, paraffin-embedded (FFPE) tissue only. FFPE is controversially discussed as source for molecular biological analyses and r
Externí odkaz:
https://doaj.org/article/97c33fa24016449e86d1a9fefb362743
Autor:
Thomas Herold, Wildfried E. E. Eberhardt, Pia-Maria Suckrau, Jeremias Wohlschlaeger, Clemens Aigner, Kurt Werner Schmid, Agnes Bankfalvi, Michael Wessolly, Fabian Dominik Mairinger, Robert Fred Henry Walter, Elena Mairinger, Balazs Hegedus, Thomas Hager, Sabrina Borchert
Publikováno v:
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology
Journal of Oncology
Background. Malignant pleural mesothelioma (MPM) is a rare, predominantly asbestos-related and biologically highly aggressive tumor associated with a dismal prognosis. Multimodal therapy consisting of platinum-based chemotherapy is the treatment of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0c8a4ac774f736984f0d5f26ef6fda
https://doi.org/10.1155/2019/2902985
https://doi.org/10.1155/2019/2902985
Autor:
Sandra Christoph, Fabian Dominik Mairinger, Thomas Mairinger, Jeremias Wohlschlaeger, Robert Fred Henry Walter, Kurt Werner Schmid, Wilfried Eberhardt, Erika Berg, Jens Kollmeier, Saskia Roxanne Sydow, Daniel C. Christoph
Publikováno v:
Cancer Management and Research. 11:8711-8720
Background Bortezomib is an approved proteasome inhibitor for the treatment of certain lymphoma subtypes. Two clinical trials investigated bortezomib in patients with malignant pleural mesothelioma (MPM) and failed to improve outcome. We present a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::889c1c5d4bac1b702a69d6463e1e1494
https://doi.org/10.2147/cmar.s194337
https://doi.org/10.2147/cmar.s194337
Autor:
Brann, Henry Walter
Publikováno v:
The German Quarterly, 1951 May 01. 24(3), 189-194.
Externí odkaz:
https://www.jstor.org/stable/401417
Autor:
Brann, Henry Walter
Publikováno v:
The German Quarterly, 1944 Nov 01. 17(4), 209-215.
Externí odkaz:
https://www.jstor.org/stable/400957